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a b s t r a c t
Objective: To develop a consensus-based set of generic competencies in antimicrobial prescribing and
stewardship for European prescribers through a structured consensus procedure.
Methods: The RAND-modified Delphi procedure comprised two online questionnaire rounds, a face-to-
face meeting between rounds, and a final review. Our departure point was a set of competencies agreed
previously by consensus among a UK multi-disciplinary panel, and which had been subsequently revised
through consultation with ESCMID Study Group representatives. The 46 draft competency points were
reviewed by an expert panel consisting of specialists in infectious diseases and clinical microbiology, and
pharmacists. Each proposed competency was assessed using a nine-point Likert scale, for relevance as a
minimum standard for all independent prescribers in all European countries.
Results: A total of 65 expert panel members participated, from 24 European countries (one to six experts
per country). There was very high satisfaction (98%) with the final competencies set, which included 35
competency points, in three sections: core concepts in microbiology, pathogenesis and diagnosing in-
fections (11 points); antimicrobial prescribing (20 points); and antimicrobial stewardship (4 points).
Conclusions: The consensus achieved enabled the production of generic antimicrobial prescribing and
stewardship competencies for all European independent prescribers, and of possible global utility. These
can be used for training and can be further adapted to the needs of specific professional groups. O.J. Dyar,
Clin Microbiol Infect 2019;25:13
© 2018 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Using antimicrobials responsibly is an essential component of
efforts to contain antimicrobial resistance (AMR), and to ensure
that patients receive appropriate treatment [1,2]. The WHO global
action plan on AMR emphasizes the importance of training
healthcare professionals in antimicrobial prescribing and stew-
ardship (AMPS) [3]. There are several challenges, however, such as
the wide range of healthcare professionals involved in the pre-
scribing process, and the heterogeneity of prescribing rights and
practices of different professional groups within and between
countries. One way to address these challenges is through devel-
oping competencies, which define the minimum standards that all
antimicrobial prescribers should reach.
Competencies can be viewed as representing a combination of
knowledge, attitudes and skills. They have successfully been used
in many healthcare disciplines, and competence-based learning
and assessment in postgraduate training is now encouraged by the
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European Union ofMedical Specialists [4,5]. There have been efforts
in individual countries to define minimum standards of compe-
tence within AMPS, including by a multi-disciplinary group in the
UK [6]. However, there is currently no widely accepted set of
competencies that is considered relevant for all independent pre-
scribers in European countries. Such a competency set could play a
significant role in harmonizing approaches in AMPS, including both
training and clinical practices.
In this context, an early draft of the UK AMPS competencies was
presented at an ESGAP (ESCMID Study Group for Antimicrobial
stewardshiP) educational workshop in 2012. This led to a consul-
tative process within ESCMID (2014e2016) to adapt their relevance
to the broader European context. The process was coordinated by
ESGAP and involved over 100 queries and contributions from Study
Groups, resulting in a set of draft competencies (see Supplementary
material, Appendix S1). Following this, the ESCMID Executive
Committee agreed that ESGAP should conduct a formal consensus
procedure with a wider group. The aim of this study was therefore
to develop a wider consensus-based set of generic AMPS compe-
tencies for prescribers across as much of Europe as possible.
Methods
Study design
We conducted a RAND-modified Delphi procedure [7e9] to
reach consensus on a set of AMPS competencies, relevant to all
independent prescribers in Europe (definitions in Box 1). We used
the term ‘antimicrobial’ throughout for consistency with existing
international work; the main focus was antibacterial agents, but
many of the competency points are relevant to other antimicro-
bials. The procedure ran between February 2017 and February 2018
and comprised four stages: (i) a first questionnaire round; (ii) an
expert panel meeting held during the ECCMID 2017 congress; (iii) a
second questionnaire round; and (iv) a final review, conducted by
e-mail. Questionnaire rounds were hosted online at SurveyMonkey
(SurveyMonkey Inc., California, USA), and data were analysed using
Microsoft Excel (Microsoft Inc., California, USA). The questionnaires
are available in the Supplementary material (Appendix S2). Our
study design did not require ethical approval.
Selection of expert panel
We shortlisted 34 European countries and invited participants
through a two-stage process. First, a potential country coordinator
was identified and invited for 31 of 34 countries (see
Supplementary material, Appendix S3, Table S1), typically an
ESGAP member with an interest and previous experience in anti-
microbial stewardship (AMS) and education. In 24 of the 31 coun-
tries, this individual agreed to participate; no response was
received from potential coordinators in the remaining seven
countries. Second, each confirmed coordinator was asked to invite
two additional participants, ideally resulting in one infectious dis-
eases specialist, one clinical microbiologist and one pharmacist per
country. Separately, 11 individuals were invited who had helped to
develop the draft competencies set, on behalf of ESCMID Study
Groups; eight agreed to participate, and three declined.
Introductory teleconferences were organized to ensure that the
expert panel had a consistent understanding of the study's aim,
definitions (Box 1) and procedure. Expert panel members were
asked to contribute their viewpoints, drawn from their own expe-
riences, rather than any from national societies or professional or-
ganizations. There was no financial compensation for participation.
First questionnaire round
The questionnaire was designed and piloted within the core
working group (comprised of the six authors). This involved
deconstructing the previously developed draft competencies into
unique competency points for appraisal of relevance. Five compe-
tency points also included ‘sub-points’, which provided specific key
points relevant to defining the competency. The competencies were
divided into three sections: (i) Infection: diagnosis, prevention and
control; (ii) Antimicrobial prescribing; and (iii) Antimicrobial
stewardship.
Invitations were sent to 74 experts, asking them to assess the
relevance of 46 competency points and 26 sub-points for all inde-
pendent prescribers in their country. A Likert scale [10] was used
ranging from 1 (‘not at all relevant’) to 9 (‘highly relevant’),
including the option ‘Cannot assess’. Sub-points were assessed
using a two-point scale (‘Include in the competency’ or ‘Do not
include’). Respondents could provide comments for each compe-
tency, including suggestions for re-phrasing, as well as proposals
for additional generic competencies. The questionnaire also con-
tained questions on participant socio-demographics and involve-
ment in AMS activities.
Competency points were accepted if the median score was 7
and70% of the expert panel member scores were in the top tertile
(scores 7, 8 or 9). Competencies were discussed at the expert panel
meeting if they had a median score 7 but <70% of the scores were
in the top tertile. Competencies with a median score <7 were
excluded. Sub-points were accepted if 80% of the expert panel
considered they should be included; scheduled for discussion
(60%e79%); or, excluded (<60%). A subgroup analysis was con-
ducted comparing median relevance scores between respondents
based on geographic region (country groupings are shown in the
Supplementary material, Appendix S3, Table S1).
Expert panel meeting
All first-round responders (referred to hereafter as ‘the expert
panel’) were sent feedback reports detailing the overall first-round
Box 1
Key definitions provided to the expert panel.
 Competencies are the minimum standards that all inde-
pendent prescribers of antimicrobials should reach to
practise according to the principles of responsible anti-
microbial use
 Generic competencies are general competencies that can
be used as a starting point by all prescribing professional
groups for developing their own more specialized
competencies
 An independent prescriber is in general an unsupervised
and unrestricted prescriber, although specific prescribing
rules vary from country to country. Examples include: Pri-
mary care/family medicine doctors, even if they can only
prescribe oral antimicrobials; First-year graduates from
medical school who can write and sign antimicrobial pre-
scriptions; Nurse or pharmacist prescribers who can pre-
scribe a range of antimicrobials for a range of clinical
conditions, without supervision. Examples do not include:
Nurse or pharmacist prescribers who can only prescribe
specific antimicrobials (e.g. trimethoprim) in specific cir-
cumstances (e.g. urinary tract infections); Final-year med-
ical students who are encouraged to write prescriptions,
but need a qualified doctor to sign the prescription.
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scores and their individual scores, and were invited to attend the
expert panel meeting either in person or via the internet. The
meeting was chaired by an external AMS expert trained in
moderating consensus procedures. The meeting aims were to (i)
present the first-round results; (ii) discuss competency points and
sub-points where there was disagreement; and (iii) discuss
whether newly suggested competencies should be considered for
assessment by the whole expert panel in a second round. Discus-
sions were held until a consensus was reached (approximately two-
thirds in agreement).
Second questionnaire round
The expert panel was invited to participate in a second ques-
tionnaire round, consisting of: (i) views on the decisions made at
the face-to-face meeting (‘Do you agree with all decisions (which
included the list of excluded competencies) made at the expert
panel meeting’); (ii) assessment of the relevance of the newly
suggested competencies, using the same scale as in the first round;
and (iii) assessment of agreement with any re-phrasings made to
the competencies.
Final review
The expert panel was sent an updated competencies set,
together with explanations for re-phrasings. Each expert was asked
whether they agreed that overall, the set of competencies as a




Eighty-eight per cent (65/74) of individuals who had agreed to
participate in the expert panel completed the first-round ques-
tionnaire in full, from all 24 countries. One partial response was
received and was not included in the analyses. Most members of
the expert panel were either doctors (72%, 47/65) or pharmacists
(22%, 14/65), specializing in either infectious diseases (51%, 33/65)
or clinical microbiology (28%, 18/65). Most were members of an
antimicrobial stewardship team (75%, 49/65), and were involved in
teaching undergraduates and/or postgraduates on antimicrobial
prescribing and/or stewardship (88%, 57/65). Full backgrounds of
the expert panel members are presented in the (Supplementary
material, (Appendix S3, Table S2)).
Fig. 1 summarizes the results from the questionnaire rounds and
face-to-face meetings. In the first round, 31 competency points
were accepted by the expert panel, 12 had disagreement and three
were excluded. Six potential new competencies were suggested.
Expert panel meeting
Thirty-eight per cent (25/66) of the expert panel members from
20 of the 24 countries attended the meeting, at which two of the 12
disputed competency points were accepted, and three new com-
petencies were selected for assessment by the whole expert panel
in the second round.
Second questionnaire round
Eighty-eight per cent (58/66) of expert panel members
completed the second-round questionnaire. Seventy-eight per cent
(52/58) stated that they agreed with all decisions from the expert
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(10%, 6/58) being the exclusion of competencies on delayed pre-
scribing. The three new competencies were accepted. The core
working group had re-phrased 13 competencies based on earlier
comments. Across the re-phrasings, there was a median 91% (range
81%e100%) agreement that the new version maintained the origi-
nally intended meaning of the competency, whilst improving its
readability.
Final review
Further re-phrasings were made based on the second-round
feedback. The final set of 35 competency points was sent to the
expert panel, with 98% of respondents (60/61, from 24/24 coun-
tries) agreeing that, overall, the competencies set was relevant for
all independent prescribers of antimicrobials in Europe.
Editorial changes
The core working group subsequently made editorial changes to
improve clarity and usability, such as re-ordering and grouping
competencies together. This final set of competencies is presented
in Box 2. The unedited list of individual competencies accepted by
the expert panel is included in the Supplementary material
(Appendix S3, List S1), together with competencies that were
assessed but ultimately excluded (Appendix S3, List S2).
Reasons for excluding competencies
Three main reasons were provided for excluding potential
competencies, throughout the consensus procedure: (i) a point was
not considered to be relevant to all independent prescribers; (ii) a
point was considered to be specialist antimicrobial stewardship
knowledge; and (iii) a point was considered to be primarily focused
on other domains.
Sub-group analysis based on region
Responses to the first-round questionnaire were further ana-
lysed based on the country of origin of the respondent, with 26
responses from north or west countries, and 39 responses from
south or east countries. Overall, there were no significant differ-
ences in responses. The median relevance scores were identical for
23 of 46 competency points and were within 1 point for 22 com-
petency points. The median relevance score differed by 1.5 points
for one competency point, which was discussed at the expert panel
meeting, and was not selected for inclusion in the final compe-
tencies set.
Discussion
We have established through a consensus procedure a set of
generic competencies in AMPS relevant to all European indepen-
dent prescribers. The competencies that achieved the high rele-
vance score required are presented in three sections. First, core
concepts in microbiology, pathogenesis and diagnosing infections
(11 points) including understanding the common microbiological
causes of infection, differences between colonization and infection,
and knowing how to diagnose common infections and use sup-
porting investigations. Second, antimicrobial prescribing (20
points), including understanding when not to prescribe antimi-
crobials, how to initiate and review antimicrobial therapy, the
clinically relevant spectrum for commonly prescribed antimicro-
bials, and documenting antimicrobial treatment plans. Third,
antimicrobial stewardship (4 points), including understanding the
need to use antimicrobials responsibly, engaging with local
stewardship policies and quality measures, and how to communi-
cate about antimicrobial treatment decisions with patients, their
carers, and other healthcare professionals.
Some of the draft competency items did not reach the threshold
for selection. Expert panel members provided three main reasons
for excluding potential competencies: (i) not relevant to all inde-
pendent prescribers (e.g. using delayed prescribing); (ii) specialist
AMPS knowledge (e.g. understanding how to use antimicrobial
usage data, knowing themodes of action of antimicrobials); (iii) out
of scope, primarily focused on other domains (e.g. infection pre-
vention and control, public health, vaccines). The inconsistency in
relevance scores for excluded items may in turn reflect differences
between countries in terms of healthcare systems, specialties,
general processes or even national cultures. For example, delaying
prescribing pending the results of microbial culture or clinical
evolutionmay reflect lack of readiness to take risks or a high level of
uncertainty avoidance [11,12]. We have listed all excluded compe-
tencies in the Supplementary material (Appendix S3, List S2),
together with their median relevance scores, to improve the po-
tential utility of this study to other specialties and professions as
well as non-participating or non-European countries.
Our study has several strengths: we used a robust methodology,
and wemade repeated efforts to ensure that expert panel members
had a consistent understanding of the study's aim, processes and
key definitions. The draft competencies set had been developed
through two earlier structured phases, first a multi-disciplinary
group in the UK [6], and second a consultative process with rep-
resentatives from multiple ESCMID Study Groups. Our study's
expert panel included representatives from 24 different countries,
with multiple respondents in all but one country. There was
extremely high satisfaction (98%) with the final competencies set,
which we think was partly due to non-attendees of the expert
panel meeting being able to comment on all proposals, and there
being a final round for further reflection on the whole competency
set. Neither of these opportunities have necessarily been included
in previous consensus procedures. Furthermore, as English is not
the first language in most European countries, another strength
was our ability to identify and re-phrase potential mis-
understandings, thus increasing the utility of the final compe-
tencies set.
Czabanowska et al. have pointed out some potential pitfalls of
Delphi procedures [13]; we believe we have avoided many of these
with our approach. The expert panel's professional backgrounds
could be considered a limitation in achieving consensus on rele-
vance for all independent prescribers: the majority were medical
doctors and pharmacists, and most of these were specialists in in-
fectious diseases or clinical microbiology. However, the draft
competencies set assessed had involved broader input earlier in its
development as the UK multi-disciplinary group included addi-
tional specialties and disciplines (e.g. surgeons, dentists, nurses)
[6]. Furthermore, the vast majority of the expert panel were
involved in AMPS teaching and were members of local AMS teams;
they therefore had practical experience of working alongside other
specialists and disciplines, and were likely to have a pragmatic
understanding of their needs and expectations.
Despite our best intentions, seven European Union countries
were not represented in this study, and this may limit the relevance
of the final competencies set for these countries. A previous study
has shown important differences throughout Europe in antimi-
crobial prescribing, so we analysed responses from the various
European regions [14]. We found no differences between re-
sponses, suggesting that, although differences in clinical practice
may exist, there was consistent agreement across different coun-
tries' representatives in terms of the minimum standards that in-
dependent prescribers should attain.
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Box 2
ESCMID generic competencies in antimicrobial prescribing and stewardship.
Section 1: core concepts in microbiology, pathogenesis and diagnosing infections
1 Every independent prescriber must understand:
1.1 The nature and classification of microorganisms that commonly cause infections in humans
1.2 The common microbiological aetiology of human infections, and the ways in which microorganisms are commonly ac-
quired in community and hospital settings
1.3 The differences between colonization (e.g. isolation of bacteria from a venous leg ulcer with no signs of inflammation) and
infection
1.4 That an inflammatory response can be due to both infectious and non-infectious causes (e.g. acute pancreatitis)
2 Every independent prescriber must know how to:
2.1 Take a thorough history and perform a physical examination to diagnose common infections and to assess their severity
2.2 Use and interpret investigations that can help in informing diagnosis of an infection and in monitoring the response to
treatment (e.g. microbiological investigations, biomarkers, point-of-care tests)
Section 2: antimicrobial prescribing
1 Every independent prescriber must understand:
1.1 How and where to access relevant guidance on antimicrobial prescribing and stewardship
1.2 When not to prescribe antimicrobials (e.g. antibiotics for viral infections, or when there is bacterial colonization)
1.3 That best practices for some infections may not include antimicrobial treatment (e.g. incision and drainage of abscesses,
removal of foreign material)
2 Every independent prescriber must understand how to select the appropriate antimicrobial, using relevant guidance when
possible, as well as the key elements of initiating prescribing an antimicrobial:
 Obtaining relevant microbiological cultures or relevant tests before commencing treatment
 The timing of antimicrobial administration in different situations (e.g. as soon as possible for life-threatening infections, less
urgently for chronic bone infections)
 The choice and dose of agent, and the route of administration
 The duration of treatment, review dates and stop dates
3 Every independent prescriber must understand the key elements of continuing and rationalizing antimicrobial therapy:
 Monitoring antimicrobial levels when indicated, and adjusting doses (e.g. for patients with renal impairment)
 Changing antibiotics according to microbiology results and clinical condition, ideally to a narrower spectrum (de-escalation),
or if needed to a broader spectrum (escalation)
 Reviewing antibiotic therapy at 48e72 hours and regularly thereafter in hospitalized patients, and in appropriate situations in
the community
 Switching antibiotics from intravenous to oral administration as soon as possible when indicated (according to guidelines)
 Stopping antimicrobials if there is no evidence of infection based on clinical findings and investigations (e.g. negative mi-
crobial cultures, imaging reports)
4 Every independent prescriber must understand the need to document the important details of the antimicrobial treatment plan
(e.g. agent, dosing, administration route, clinical indication, duration and review dates) in the prescription chart, medical re-
cords and transfer notes to other healthcare institutions
5 Every independent prescriber must understand:
5.1 That empirical treatment should be guided by local antimicrobial susceptibility patterns
5.2 The clinically relevant spectrum of activity for commonly prescribed antimicrobials
5.3 The basic principles of pharmacokinetics and pharmacodynamics
6 When prescribing an antimicrobial, every independent prescriber must know:
6.1 The antimicrobial class that the agent belongs to, and the contraindications to its use
6.2 The name and class of antimicrobial being prescribed, if prescribing by trade name
7 Every independent prescriber must understand single prophylactic dosing for surgical and other procedures for which pro-
phylaxis has been shown to be effective, and that additional prophylactic antimicrobial doses can occasionally be needed (e.g.
when the duration of the operation/procedure is prolonged)
8 Every independent prescriber must know:
8.1 Common antimicrobial and drug/food interactions
8.2 Common side-effects of antimicrobials, including allergy, how tomonitor for them, andwhat to dowhen they are suspected
(e.g. documenting allergic reactions in patient records, reporting side-effects)
9 Every independent prescriber must understand any legal requirements for prescribing antimicrobials in their country, and
comply with these when prescribing
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This, the first set of internationally agreed generic competencies
in AMPS for all independent prescribers in Europe, has several
potential uses. The competencies can be used by regulators and
professional bodies to inform standards [5,15]; by undergraduate
and postgraduate educators to design curricula, create teaching
materials and assess outcomes [16,17]; and by individuals to
monitor their own competency. Where relevant, ideally these uses
would be in conjunction with any existing competencies on infec-
tion prevention and control, and vaccine use.
The WHO recently published a competency framework for
health workers' education and training on AMR [15], developed
through a global mapping of education and training resources and
refined through expert consultation.We shared an early draft of our
competencies with those leading the process, and this is referenced
in the final publication. We believe that our final competencies set
complements this framework, and there is indeed overlap on
several points. Nonetheless, a few differences should be recognized.
A major difference is that we followed a structured consensus
methodology, inwhich each expert panel member is provided with
an equal voice, and in which we attempted to have equal repre-
sentation across a large number of European countries. Further-
more, our focus was narrower in terms of target groups and
content: our set is primarily intended for prescribers in European
countries (a more homogeneous group than all prescribers glob-
ally), and our set is restricted to AMPS, rather than broader aspects
related to AMR (infection prevention and control, surveillance,
leadership). Consequently, many individuals in Europe whose pri-
mary focus is AMPSmay find it easier tomake immediate use of our
set.
Over the coming years ESCMID and ESGAPwill support efforts to
implement these ESCMID generic competencies in antimicrobial
prescribing and stewardship, including encouraging other profes-
sional societies to tailor the competencies set to their members'
needs. Such adaptations could include adding further compe-
tencies, for example competency points that were excluded in our
consensus process because they were considered relevant to spe-
cific groups of prescribers, rather than to all independent pre-
scribers (see Supplementary material, Appendix S3, List S2)).
Although the competencies set was developed for European
countries, we believe that the majority of the accepted compe-
tencies are relevant to prescribers working in a far broader range of
settings, as evidenced by the overlap with the WHO competency
framework. The timing of these initiatives is particularly urgent
given the ever-increasing threats of AMR to effective antimicrobial
therapy and the need for global activity to prevent and combat its
spread [3,18].
Transparency declaration
The authors declare that they have no conflicts of interest.
Funding
This work was supported through an ESCMID Study Group
research fund grant (number 307e18).
Acknowledgments
The ESCMID generic competencies working group consisted of:
Diane Ashiru-Oredope, Istvan Barcs, Hege Salvesen Blix, Franky
Buyle, Michal Chowers, Milan Cizman, Barry Cookson, Jose Luis Del
Pozo, Aleksander Deptula, Uga Dumpis, Dragos Florea, Ewoudt van
de Garde, Yuval Geffen, Christian G. Giske, Santiago Grau, Edit
Hajdú, Markus Hell, Łukasz Hondo, Khetam Hussein, Benedikt
Huttner, Winfried Kern, Solen Kerneis, Viviane Knepper, Diamantis
Kofteridis, Tomi Kostyanev, Ed Kuijper, Hristina Lebanova, Russell
Lewis, Claire Marantidis Cordina, Raimonda Matulionyte, Florian
Maurer, Peter Messiaen, Jolanta Miciuleviciene, Ales Mrhar, Mar-
rigje Nabuurs-Franssen, Reinout Naesens, Cynthia Oxacelay, Leo-
nardo Pagani, Jose Ramon Pa~no-Pardo, Mical Paul, Georgios
Petrikkos, Catherine Pluess-Suard, Gabriel Adrian Popescu, Ulla
Porsche, Jan Prins, Celine Pulcini, Jordi Rello, Jesús Rodríguez-Ba~no,
Gian Maria Rossolini, Bernd Salzberger, Katja Seme, Gunnar Skov
Simonsen, Mardale Sînziana, Sissel Skovgaard, Ingrid Smith, Ute
S€onsken, Alex Soriano, Inese Sviestin¸a, Emese Szilagyi, Thomas
T€angden, Pierre Tattevin, Constantinos Tsioutis, Aija Vilde, Monika
Wanke-Rytt, AgnesWechsler-F€ord€os and Peter Zarb. Wewould like
to acknowledge the following individuals and study groups who
contributed to the consultative process within ESCMID that led to
the competencies set used as the basis of this study: ESGAP (Barry
Cookson, Bojana Beovic, Diane Ashiru-Oredope, Celine Pulcini, Dilip
Nathwani); ESGNI (Markus Hell); ESGIAI (Alex Soriano); ESGIE
Section 3: antimicrobial stewardship
1 Every independent prescriber must understand that:
1.1 Antimicrobials need to be used responsibly to prevent the emergence and spread of antimicrobial resistance
1.2 Optimizing antimicrobial use can limit the common side-effects and collateral damage related to treatment (e.g. their
disruptive effects on the normal host flora, which may lead to Clostridium difficile infection, super-infection with Candida
spp.)
1.3 It is important to avoid unnecessary uses of antimicrobials, especially those with a broad spectrum
1.4 Transmission of microorganisms in community and hospital settings can significantly amplify antimicrobial resistance
2 Every independent prescriber must understand local stewardship policies based on national (or international where these do
not exist) evidence-based guidelines
3 Every independent prescribermust understand and engagewith any locally or nationally agreed qualitymeasures for assessing
antimicrobial prescriptions (e.g. compliance with guidance, adverse events, reviews of antibiotic therapy at 48e72 hours in
hospitalized patients)
4 Every independent prescriber must know how to communicate with patients and their carers, nurses, pharmacists and other
healthcare professionals about:
4.1 When antimicrobials are not needed
4.2 Complying with the duration and frequency of administration of their prescribed antimicrobials
5 Every independent prescriber must recognize that it is a duty of care to co-operate with othersmore expert than oneself, such as
the antimicrobial stewardship team, when such expertise is needed
O.J. Dyar et al. / Clinical Microbiology and Infection 25 (2019) 13e1918
(Mical Paul); ESGCIP (Jordi Rello); ESGBIS (W. Joost Wiersinga);
ESGCD (Ed Kuijper); ESCMID executive committee (Evelina Tacco-
nelli, Jesús Rodríguez-Ba~no). We also thank Jeroen Schouten for
chairing the expert panel meeting. A poster describing the results of
this study was presented at the 28th European Congress of Clinical
Microbiology & Infectious Diseases, in Madrid, Spain, on 23 April
2018.
Appendix A. Supplementary data
Supplementary data to this article can be found online at
https://doi.org/10.1016/j.cmi.2018.09.022.
References
[1] ESCMID/ESGAP. Antimicrobial stewardship. 1st ed. Cambridge, MA: Academic
Press; 2017.
[2] Dyar OJ, Huttner B, Schouten J, Pulcini C, ESGAP (ESCMID Study Group for
Antimicrobial stewardshiP). What is antimicrobial stewardship? Clin Micro-
biol Infect 2017;23:793e8.
[3] WHO. Global action plan on antimicrobial resistance. 2015. http://apps.who.
int/gb/ebwha/pdf_files/WHA68/A68_R7-en.pdf?ua¼1. [Accessed 20 April
2017].
[4] Carrico RM, Rebmann T, English JF, Mackey J, Cronin SN. Infection prevention
and control competencies for hospital-based health care personnel. Am J
Infect Control 2008;36:691e701.
[5] European Union of Medical Specialists. Competence-Based training and
assessment n.d. https://www.uems.eu/areas-of-expertise/postgraduate-
training/competence-based-training-and-assessment (accessed 26 July 2018).
[6] Ashiru-Oredope D, Cookson B, Fry C, Cookson B, Ashiru-Oredope D, Avery T,
et al. Developing the first national antimicrobial prescribing and stewardship
competences. J Antimicrob Chemother 2014;69:2886e8.
[7] Dalkey N. The Delphi method: an experimental study of group opinion. Santa
Monica, CA: RAND Corp; 1969.
[8] Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. The
RAND/UCLA appropriateness method user’s manual. Transformation. 2001.
[9] Campbell SM, Braspenning J, Hutchinson A, Marshall MN. Improving the
quality of health care: research methods used in developing and applying
quality indicators in primary care. BMJ 2003;326:816e9.
[10] Likert R. A technique for the measurement of attitudes. Arch Psychol
1932;140:1e55.
[11] Hofstede G, Hofstede GJ, Minkov M. Cultures and organizations: software of
the mind. 3rd ed. New York: McGraw-Hill Education; 2010.
[12] Borg MA, Camilleri L, Waisfisz B. Understanding the epidemiology of MRSA in
Europe: do we need to think outside the box? J Hosp Infect 2012;81:251e6.
[13] Czabanowska K, Smith T, K€onings KD, Sumskas L, Otok R, Bjegovic-
Mikanovic V, et al. In search for a public health leadership competency
framework to support leadership curriculum e a consensus study. Eur J Public
Health 2014;24:850e6.
[14] Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C,
et al. European surveillance of antimicrobial consumption (ESAC): outpatient
antibiotic use in Europe. J Antimicrob Chemother 2006;58:401e7.
[15] World Health Organisation. WHO competency framework for health workers’
education and training on antimicrobial resistance. Geneva: WHO; 2018.
[16] European Centre for Disease Prevention and Control. Catalogue of infection
control and hospital hygiene courses in the European Union e 2016. Stock-
holm: ECDC; 2017.
[17] Dyar OJ, Nathwani D, Monnet DL, Gyssens IC, Stålsby Lundborg C, Pulcini C,
et al. Do medical students feel prepared to prescribe antibiotics responsibly?
Results from a cross-sectional survey in 29 European countries. J Antimicrob
Chemother 2018. https://doi.org/10.1093/jac/dky150.
[18] Allerberger F, Gareis R, Jindrak V, Struelens MJ. Antibiotic stewardship
implementation in the EU: the way forward. Expert Rev Anti Infect Ther
2009;7:1175e83.
O.J. Dyar et al. / Clinical Microbiology and Infection 25 (2019) 13e19 19
